Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Similar to biotech, startups are the primary drivers of disruptive innovation in quantum. The 'neutral atoms' modality, once dismissed as science fiction, was championed by startups and is now a leading contender, forcing incumbents like Google to invest heavily to hedge against their established approaches.

Related Insights

According to a partner at Radical Ventures, the frontier for AI startups is expanding beyond software ('bits') into the physical world ('atoms'). The next wave of high-impact AI companies will tackle complex challenges in sectors like energy, critical minerals, and manufacturing.

Startups can make big bets on emerging workloads, like LLMs before they were proven. This is a product risk. In contrast, incumbents like Google or NVIDIA must ensure their next chip serves a wide range of existing customers, forcing them to be more conservative and avoid disruptive product bets.

While domain experts are great at creating incremental improvements, true exponential disruption often comes from founders outside an industry. Their fresh perspective allows them to challenge core assumptions and apply learnings from other fields.

AI-native startups hold a key long-term advantage over established players. Incumbents often struggle to integrate transformative AI because it threatens to cannibalize their existing, profitable business models. AI-native companies, built from the ground up, face no such constraints and can pursue more disruptive strategies.

The core conflict is whether a startup can achieve mass distribution before the incumbent can replicate its core innovation. Historically, incumbents have an advantage because they eventually catch up on technology. AI may accelerate this, making a startup's unique and rapid path to acquiring customers more critical than ever.

The quantum industry's structure, with its various modalities (like drug types) and long, high-risk development cycles, mirrors biotech. Policies should adopt similar models, like advanced market commitments and support for phase-based trials, to accelerate commercialization.

Incumbents face the innovator's dilemma; they can't afford to scrap existing infrastructure for AI. Startups can build "AI-native" from a clean sheet, creating a fundamental advantage that legacy players can't replicate by just bolting on features.

While AI dominates current conversations, Techstars' David Cohen believes Quantum Computing represents a far larger future paradigm shift. He posits that a single quantum computer will eventually surpass the combined power of all AI-driven classical computers. The "killer app" for this new era will be in healthcare, enabling truly personalized medicine.

Nvidia CEO Jensen Huang's public stance on quantum computing shifted dramatically within months, from a 15-30 year timeline to calling it an 'inflection point' and investing billions. This rapid reversal from a key leader in parallel processing suggests a significant, non-public breakthrough or acceleration is underway in the quantum field.

Significant change doesn't come from the established core of an industry but from the margins. This is where smaller, private companies and overlooked founders operate, making private markets a crucial hunting ground for the most disruptive investment opportunities.